Ol fragmentation in the course of the hydrolysis, which was otherwise facile, specifically with aromatic aldol addition merchandise. Within a noteworthy instance, use with the THFmethanol-sodium hydroxide protocol with substrate 10 afforded the aromatic aldolate 25 in 94 yield and 98 ee (DYRK4 medchemexpress auxiliary recovery: 97 yield). A protected type of the latter amino acid served as a important starting material inside the synthesis of vancomycin reported by the Nicolaou group. Interestingly, the present hydrolysis situations are much milder than these essential for hydrolysis of pseudoephedrine and pseudoephenamine[2b] amide alkylation products,Angew Chem Int Ed Engl. Author manuscript; accessible in PMC 2015 April 25.Seiple et al.Pagesuggesting that the -hydroxy group on the aldol adducts may perhaps facilitate N O-acyl transfer. Within this regard, it really is notable (even though not surprising) that X-ray crystallographic analysis (structures 4 and 16) reveals an internal hydrogen bond involving the amide carbonyl groups and their -hydroxy functions. We believe that facile hydrolysis (and reduction, vide infra) of pseudoephenamine amide aldol solutions happens by fast N O-acyl transfer followed by saponification (reduction) of the resulting -amino ester, as we’ve previously proposed for alkaline hydrolyses of pseudoephedrine amides. The -amino sodium carboxylates obtained upon alkaline hydrolysis is usually converted to amino acid methyl esters upon exposure to acidic methanol (e.g., 20 26, Scheme two). Alternatively, treatment of the identical substrates with di-tert-butyldicarbonate affords N-Bocprotected amino acids in higher yield (e.g., 23 27, Scheme 2). The N-Boc -amino acid 27 is noteworthy for it serves as precursor to the fully synthetic monobactam antibiotic BAL30072, that is at present in phase I clinical MDM-2/p53 site trials as an anticipated remedy for infections brought on by Gram-negative bacteria. Alkaline hydrolysis conditions were not uniformly prosperous with every single substrate; in certain instances retroaldol fragmentation was more rapidly than hydrolysis, even when employing our optimal protocol. For instance, therapy on the ketone aldol adduct 17 with 1 equiv of sodium hydroxide in 1:1 methanol:water at 23 supplied mostly three products: acetophenone, pseudoephenamine, and sodium glycinate (the latter two products presumably result from hydrolytic cleavage of 1); none on the preferred -hydroxy–amino sodium carboxylate was observed. We envisioned that retroaldol fragmentation will be avoided when the hydroxy substituent have been shielded, and for this goal we chose a cyclic carbamate, which can easily be introduced and removed under extremely mild conditions and has the added benefit of safeguarding the -amino function. Therapy of aldol adduct 17 with phosgene (1.1 equiv) and diisopropylethylamine (3 equiv) at -78 in dichloromethane formed inside 30 min the cyclic carbamate 28, isolated in pure form by straightforward aqueous extraction. While carbamate 28 was resistant to alkaline hydrolysis (presumably due to the acidity in the carbamate function) we discovered that heating a option of 28 in a 1:1 mixture of dioxane and pure water at reflux for 24 h effected clean hydrolysis with the auxiliary. Simple acidbase extraction then provided acid 29 in 85 yield (and, separately, pseudoephenamine in 97 yield). By an analogous sequence, therapy of aldol adduct 18 with phosgene supplied carbamate 30, (the stereochemistry of which was rigorously established by X-ray crystallography). This intermediat.